Current Opinion in Oncology

Article	Citations
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy	47
Can febrile neutropenia re-invent its self?	42
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?	29
Pathology and new insights in thyroid neoplasms in the 2022 WHO classification	24
The road to chemotherapy-free treatment in chronic lymphocytic leukaemia	24
New treatments for desmoid tumors	22
Challenges adopting next-generation sequencing in community oncology practice	22
The multiple molecular dimensions of long noncoding RNAs that regulate gene expression and tumorigenesis	19
Genomic tests for risk stratification in patients with early human epidermal growth factor receptor 2-positive breast cancer	18
Targeting SUMOylation in cancer	18
Harnessing dendritic cells for innovative therapeutic cancer vaccines	17
Novel PET tracers in breast cancer for treatment optimization: clinical utility and future perspectives	17
Controversies on chemotherapy for early HR+/HER2− breast cancer: the role of anthracyclines and dose intensification	17
The roaring 2020s: a new decade of systemic therapy for renal cell carcinoma	17
Anal squamous cell carcinoma: standards of care, new data and ongoing clinical trials	16
The impact of new and emerging agents on outcomes for febrile neutropenia: addressing clinical gaps	16
First and further-line multidisciplinary treatment of retroperitoneal sarcomas	14
Angiogenesis inhibition in lung cancer: emerging novel strategies	13
Treatment of anaplastic gliomas: evidences and controversies	13
Two is company, is three a crowd? Triplet therapy, novel molecular targets, and updates on the management of advanced renal cell carcinoma	13
Pathologic diagnosis of lung cancer – recent developments	13
Editorial: Head and neck squamous cell cancer: ways to optimize the treatment and improve the outcomes	12
Opportunities and challenges of neoadjuvant targeted therapy in nonsmall cell lung cancer	12
Hepatosplenic T-cell lymphoma: treatment challenges	12
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitis	12

Editorial introductions	12
Editorial introductions	12
Advances in the treatment of light chain amyloidosis	11
Breast surgery after neoadjuvant therapy	11
Psycho-oncology interventions focusing on fatigue and sleep disturbances	10
Robot-assisted laparoscopic staging compared to conventional laparoscopic staging and laparotomic staging in clinical early stage ovarian carcinoma	10
Bacterial infection-driven lymphomagenesis	10
Novel therapeutic agents for myelofibrosis after failure or suboptimal response to JAK2 inhbitors	9
Recent advances in allogeneic transplantation for acute myeloid leukemia	9
Postneoadjuvant treatment for triple-negative breast cancer	9
Mind the target: human epidermal growth factor receptor 2 in colorectal cancer	9
Deciphering diffuse glioma immune microenvironment as a key to improving immunotherapy results	9
Treatments and challenges in advanced prostate cancer	9
Evolving systemic management of urothelial cancers	8
Epigenetic dynamics of aging and cancer development: current concepts from studies mapping aging and cancer epigenomes	8
Nanoparticle therapy for head and neck cancers	8
Adjuvant and neoadjuvant approaches in pancreatic cancer	8
New strategies for the treatment of breast cancer with leptomeningeal metastasis	8
Neurorehabilitation in brain tumours: evidences and suggestions for spreading of knowledge and research implementation	8
Preclinical glioma models in neuro-oncology: enhancing translational research	8
Editorial: Psychological interventions in oncology: advances and challenges	8
New targeted therapies in liposarcoma: state of art and future perspectives	7
Survivorship after Hodgkin lymphoma and the right to be forgotten	7
Targeting cancer stem cell pathways for lung cancer therapy	7
Targeting androgen biosynthesis in prostate cancer: implications on endocrine physiology	7
Circulating tumour DNA dynamics for assessment of molecular residual disease and for intercepting resistance in breast cancer	7
State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies	7
Immune checkpoint inhibitors as adjuvant therapy in patients with completely resected nonsmall cell lung cancer	7
Antibody-drug conjugates in solid tumors: a new frontier	7
Content features and its implementation in novel app-based psycho-oncological interventions for cancer survivors: a narrative review	7
Treatment of small cell lung cancer: recent advances	6
Biomarker-directed therapy in multiple myeloma	6
Clinician's guide to targeted estrogen receptor degradation using PROTAC in patients with estrogen receptor-positive metastatic breast cancer	6
The role of signaling lymphocyte activation molecule family receptors in hematologic malignancies	6
Biomarkers and immunotherapy: where are we?	6
Advances in the pathogenesis of FLT3-mutated acute myeloid leukemia and targeted treatments	6
Immunotherapy in first line treatment of adult acute lymphoblastic leukemia	6
Editorial introductions	6
Integrating new oral selective oestrogen receptor degraders in the breast cancer treatment	6
HTLV-1-related adult T-cell leukemia/lymphoma: insights in early detection and management	6
Tropomyosin receptor kinases in sarcomas – of joy and despair	6
When do I ask for a DNA methylation array for primary brain tumor diagnosis?	6
New targeted treatments for advanced sarcomas	6
Unveiling the enigma of the blood–brain barrier in glioblastoma: current advances from preclinical and clinical studies	6
Transcriptional and epigenetic control of early life cell fate decisions	6
Immunotherapy and breast cancer: an overview	5
Educational needs of self-care in cachectic cancer patients and caregivers	5
Stereotactic ablative radiation therapy in metastatic prostate cancer	5
Beyond ‘the good, the bad and the ugly’: let us put rectal cancer patients at the centre of the decision making	5
Neoadjuvant and adjuvant approaches in gastroesophageal cancers	5

Benefits of sentinel node detection in cervical cancer	5
Impact of sentinel node implementation in gynecologic cancers	5
Current treatments of medulloblastoma	5
Sarcoma incidence worldwide: regional differences in histology and molecular subtypes	5
Recent advances in radiosensitivity determinants in melanoma	5
State-of-the-art and trends in fibroblast growth factor receptor-directed therapies in gastro-intestinal malignancies	5
Treatment of radiation-associated angiosarcoma	5
Importance of guidelines and networking for the management of rare gynecological cancers	5
Immunotherapies in non-metastatic gastrointestinal cancers	5
Genetic testing in patients with triple-negative or hereditary breast cancer	5
Impact of sentinel node use in lymphedema formation among gynecologic cancer patients	5
Editorial: Advanced care planning	5
Advances in testing for human papillomavirus-mediated head and neck cancer	5
Image-guided surgery in oral cancer: toward improved margin control	4
Editorial: Supportive care in cancer patients: quo vadis?	4
Challenges in the management of relapsed germ cell tumors	4
Changes in the therapeutic landscape of oesophago-gastric cancers	4
Local treatment in patients with hereditary breast cancer: decision-making process in low-, moderate-, high-penetrance pathogenic germline mutation carriers	4
Is less more in the surgical treatment of early-stage cervical cancer?	4
Editorial introductions	4
Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?	4
What is the standard indication of adjuvant or neoadjuvant chemotherapy in localized soft-tissue sarcoma?	4
Immunotherapy for inflammatory breast cancer: current evidences and future perspectives	4
State of the art and future directions in the systemic treatment of medullary thyroid cancer	4
Application of natural killer immunotherapy in blood cancers and solid tumors	4
The evolving treatment landscape of advanced urothelial carcinoma	4
Editorial introductions	4
Editorial introductions	4
Safety of assisted reproductive techniques in gynecological cancer patients	4
HER2-positive breast cancer: cotargeting to overcome treatment resistance	4
Editorial introductions	4
How to prevent human papillomavirus-related oropharyngeal cancer?	4
New hopes in relapsed refractory primary central nervous system lymphoma	4
Venetoclax in combination with nucleoside analogs in acute myelogenous leukemia	4
New horizons in early drugs development in solid cancers	4
Hairy cell leukemia: a brief update on current knowledge and treatment prospects	3
WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification	3
Epigenetic focus on angioimmunoblastic T-cell lymphoma: pathogenesis and treatment	3
Ten steps to establish a national centre for gestational trophoblastic disease	3
Beyond ibrutinib: novel BTK inhibitors for the treatment of chronic lymphocytic leukemia	3
Editorial: precision medicine of sarcomas and aggressive connective tissue tumours: from one-size-fits-all to haute couture	3
Prophylactic cranial irradiation in small cell lung cancer: an update	3
Current limits of conservative treatment in ovarian cancer	3
Emerging therapies in Ewing sarcoma	3
Editorial introductions	3
Circulating tumor DNA in breast cancer: a biomarker for patient selection	3
Current treatment options for nodular lymphocyte-predominant Hodgkin lymphoma	3
Prognostic factors in primary central nervous system lymphoma	3
Are advancements in screening technology contributing to breast cancer over-diagnosis?	3
Surgical management of skull base meningiomas and vestibular schwannomas	3
CIC-DUX4 sarcomas	3
Question prompt lists to improve communication between cancer patients and healthcare professionals	3
Unveiling the role of cellular dormancy in cancer progression and recurrence	3
The role of next-generation sequencing in acute myeloid leukemia	3
State-of-the-art and upcoming trends in RAS-directed therapies in gastrointestinal malignancies	3
How to treat localized Hodgkin lymphoma?	3
Collaborative centralization of gynaecological cancer care	3
Immune checkpoint inhibitors in driver mutation-positive nonsmall cell lung cancer	3
BRAF mutations in thyroid cancer	3
Bromodomain and extraterminal domain protein bromodomain inhibitor based cancer therapeutics	3
New molecular entities of soft tissue and bone tumors	3
High-risk, recurrent and oligometastatic prostate cancer: recent developments on the role of radiation	3
COVID-19 and supportive cancer care: key issues and opportunities	3
Updated concepts in treatment of giant cell tumor of bone	3
Epidemiology trends and progress in breast cancer survival: earlier diagnosis, new therapeutics	3
Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancer	3
Mutational burden and immune recognition of gliomas	3
Next-generation sequencing for the management of sarcomas with no known driver mutations	3
Editorial introductions	2
Kirsten rat sarcoma inhibitors in clinical development against nonsmall cell lung cancer	2
Diligent use of MedDRA terminology and preferred term selection in safety reports of clinical trials	2
HIV-related lymphomas	2
Supportive care centers: definition of excellence	2
A challenging frontier – the genomics and therapeutics of nonclear cell renal cell carcinoma	2
Systemic treatment of recurrent and/or metastatic squamous cell carcinomas of the head and neck: what is the best therapeutic sequence?	2
Thoracic irradiation as consolidation therapy in patients with extensive-stage small cell lung cancer	2
Tripartite motif family – its role in tumor progression and therapy resistance: a review	2
Clinical utility of genomic signatures for the management of early and metastatic triple-negative breast cancer	2
Editorial Introductions	2
Therapeutic cancer vaccination against telomerase: clinical developments in melanoma	2

A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?	2
Surgical treatment for clinical early-stage expansile and infiltrative mucinous ovarian cancer: can staging surgeries safely be omitted?	2
The conquest of lung cancer in Central Europe	2
Radiation therapy on the axilla after neoadjuvant chemotherapy	2
Advance care planning in oncology: a scoping review and some recommendations	2
Measurable residual disease in peripheral blood in myeloma: dream or reality	2
Thinking through the multimodal treatment of localized oesophageal cancer: the point of view of the surgeon	2
Gynecological sarcomas: literature review of 2020	2
Editorial introductions	2
Current status of phosphoinotiside-3 kinase inhibitors in blood cancers	2
Targeting Harvey rat sarcoma viral oncogene homolog in head and neck cancer: how to move forward?	2
Next questions for the medical treatment of gastrointestinal stromal tumor	2
Preclinical models to understand the biology and to discover new targets in brain metastases	2
New boundaries for fertility sparing management in endometrial cancer	2
Clinical management of brain tumors in pregnancy	2
Use of staging for sex cord stromal tumours	2
Editorial: Chromatin dynamics and immunosurveillance – two sides of the cancer ‘cell identity crisis’	2
Imaging for illuminating actionable pathways in breast cancer	2
What is the best salvage therapy for Hodgkin lymphoma?	2
Oral microbiome as a new research-target for supportive care and precision oncology	2
Management of metastatic melanoma with new immunotherapy approaches beyond PD-1/CTLA-4 inhibitors	2
Melanoma with genetic alterations beyond the BRAF V600 mutation: management and new insights	2
Potential subtype-specific therapeutic approaches in small cell lung cancer	2
Accelerating drug access from advanced to early breast cancer: the special case of oral selective estrogen receptor degraders	2
Altered hormone expression induced genetic changes leads to breast cancer	2
Ovarian preservation in gynecologic oncology: current indications and techniques	2
Single agent vs combination immunotherapy in advanced melanoma: a review of the evidence	2
Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphoma	2
Editorial Introductions	2
New perspectives in liquid biopsy for glioma patients	2
Mind the target: circulating tumour DNA in gastrointestinal malignancies	1
Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine	1
Novel next-generation sequencing-based methodologies to characterize the mutational consequences of (prenatal) chemotherapy exposure in noncancerous tissue	1
Novel immunotherapeutic approaches in lung cancer: driving beyond programmed death-1/programmed death ligand-1 and cytotoxic T-lymphocyte-associated Protein-4	1
Editorial introductions	1
Immunotherapy in rare ovarian cancer	1
Reproductive life and differentiated thyroid carcinoma in women: reciprocal influences on their respective outcome	1
Fasting-mimicking diet: a metabolic approach for the treatment of breast cancer	1
How to monitor the side effects of treatments in cancer patients	1
Molecular testing of DNA damage response pathways in prostate cancer patients	1
Lung cancer screening in never smokers	1
Editorial: Head and neck cancers: recent pathological approaches and new therapeutic guidelines for sino-nasal, thyroid and squamous cell carcinomas	1
First line treatments in primary central nervous system lymphomas in young patients	1
Dyadic psychosocial interventions for patients with cancer and their caregivers: an update	1
The role and underlying mechanisms of tumour-derived exosomes in lung cancer metastasis	1
Molecular genotyping of adrenocortical carcinoma: a systematic analysis of published literature 2019–2021	1
Multiple endocrine neoplasia type 2: towards a risk-based approach integrating molecular and biomarker results	1
Prophylactic cranial irradiation for small cell lung cancer in the era of immunotherapy and molecular subtypes	1
Editorial: Lung cancer: continuous progress in diagnosis and treatment	1
Immunomodulation for hepatocellular carcinoma therapy: current challenges	1
Recent advances in precision medicine for acute myeloid leukemia	1
Current “state of the art” on dendritic cell-based cancer vaccines in melanoma	1
New developments in rare vulvar and vaginal cancers	1
Fms-like tyrosine kinase 3 positive acute myeloid leukemia	1
The role of the tumor matrix environment in progression of head and neck cancer	1
Preoperative immunotherapy for head and neck cancers: state of art	1
Liquid biopsy in head neck cancer: ready for clinical routine diagnostics?	1
State of the art and future directions in the systemic treatment of neuroendocrine neoplasms	1
Perioperative immunotherapy for nonsmall cell lung cancer	1
Maintenance therapies in acute myeloid leukemia: the renaissance of an old therapeutic concept	1
Psychological interventions targeting patients with metastatic cancer and prolonged survival expectancies: advances and challenges	1
Interventions aiming to improve advance care planning uptake in oncology: a scoping review of recent randomized controlled trials	1
Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant glioma	1
Pregnancy-related hormonal changes and thyroid growth: do they have an impact on the higher incidence of differentiated thyroid cancer in women?	1
Supportive care for new cancer therapies	1
Liquid biopsy in brain tumors: moving on, slowly	1
Novel strategies to improve efficacy of treatment with tumor-infiltrating lymphocytes (TILs) for patients with solid cancers	1
Pathology and new insights in central nervous system lymphomas	1
Achievements of international rare cancers networks and consortia in the neuro-oncology field	1
Advances in myelodysplastic syndrome	1
Update on bi-specific monoclonal antibodies for blood cancers	1
Cancer-associated thrombosis: what is new?	1
Molecular oncology: what is needed to speed access to innovative therapies in clinical research?	1
Active surveillance in favorable intermediate risk prostate cancer: outstanding questions and controversies	1
Chemotherapy postimmunotherapy for recurrent metastatic head and neck squamous cell carcinoma	1
Thymic malignancies: role of immunotherapy and novel approaches	1
Anaplastic thyroid carcinoma: advances in molecular profiling and targeted therapy	1
Editorial introductions	1
Action against thoracic cancers: recent achievements and perspectives	1
Retroperitoneal sarcoma: the Transatlantic Australasian Retroperitoneal Sarcoma Working Group Program	1
Novel vaccines against lung cancer	1